US5374515A
Expired / Lapsed
US
⏱️ 0.0 years remaining
In vitro cornea equivalent model
Assignee: PRESDENT AND FELLOWS OF HARVRD COLLEGE
•
Filing: 1992-11-13
•
Granted: 1994-12-20
•
Expires: 2012-11-13
Abstract
Abstract This invention is directed to an organ equivalent of the cornea part of the eye made using tissue culturing systems. The method of constructing the cornea equivalent results in a structure analogous to the eye cornea in vivo. The cornea equivalent is an in vitro model of the eye, which can be used for transplantation or implantation in vivo or for screening compounds in vitro.
Inventors
- 👤 Nancy L. Parenteau
- 👤 Valerie S. Mason
- 👤 Bjorn R. Olsen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:26
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/38; A61L27/3886; A61L27/3891; A61F; A61F2/00; A61F2/02; A61F2/14; A61F2/142; A61K; A61K35/00; A61K35/12; A61L27/14; A61L27/22; A61L27/24; A61L27/3804; A61L27/3808; A61L27/3813; A61L27/3839; A61L27/3895; C; C12; C12N; C12N5/00; C12N5/0062; C12N5/06; C12N5/0602; C12N5/0618; C12N5/0621; C12N5/0697; A61L2430/00; A61L2430/16; C12N2500/00; C12N2500/05; C12N2500/10; C12N2500/20; C12N2500/24; C12N2500/25; C12N2501/00; C12N2501/30; C12N2501/38; C12N2501/39; C12N2501/395; C12N2502/00; C12N2502/08; C12N2502/085; C12N2502/09; C12N2502/094; C12N2502/13; C12N2502/1323; C12N2510/00; C12N2510/04; C12N2533/00; C12N2533/50; C12N2533/54
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
58 words
A cornea equivalent comprising: (a) an inner endothelial cell layer, wherein said endothelial cells are derived from mammalian corneal endothelial cells; (b) a middle stromal cell-collagen mixture layer, wherein said stromal cells are derived from mammalian corneal stromal fibroblast cells; and (c) an external epithelial cell layer, wherein said epithelial cells are derived from mammalian corneal epithelial cells.
Claim 2
Dependent Claim
58 words
A cornea equivalent comprising: (a) an inner endothelial cell layer, wherein said endothelial cells are derived from mammalian corneal endothelial cells; (b) a middle stromal cell-collagen mixture layer, wherein said stromal cells are derived from mammalian corneal stromal fibroblast cells; and (c) an external epithelial cell layer, wherein said epithelial cells are derived from mammalian corneal epithelial cells.
Claim 3
Dependent Claim
31 words
The cornea equivalent of claim 1, wherein said endothelial cells of said inner endothelial cell layer are derived from mammalian corneal endothelial cells transformed with the large T antigen of SV40.
Claim 4
Dependent Claim
74 words
The cornea equivalent as in either claim 1 or claim 2 wherein the collagen in said middle stromal cell-collagen mixture layer is selected from the group consisting of acid extracted bovine tendon collagen, enzyme extracted bovine tendon collagen, rat tail collagen, Type I collagen extracted from dermis, Type III collagen extracted from dermis, Type I collagen extracted from corneal stroma, Type V extracted from corneal stroma, and Type VI collagen extracted from corneal stroma.
Claim 5
Dependent Claim
21 words
The cornea equivalent of claim 3, wherein said collagen is a mixture of Types I and III collagen extracted from dermis.
Claim 6
Dependent Claim
23 words
The cornea equivalent of claim 3, wherein said collagen is a mixture of Types I, V and VI collagen extracted from corneal stroma.
Claim 7
Independent Claim
158 words
The method of producing a cornea equivalent comprising: (a) culturing endothelial cells to form an inner endothelial cell layer, wherein said endothelial cells are derived from mammalian corneal cells; (b) mixing stromal cells with collagen to achieve a stromal cell-collagen mixture, wherein said stromal cells are derived from mammalian corneal stromal fibroblast cells; (c) contacting said inner endothelial cell layer of step (a) with said stromal cell-collagen mixture of step (b), thereby forming a middle layer provided on said inner layer; (d) culturing said inner endothelial cell layer and said middle layer; (e) contacting epithelial cells onto said middle layer of step (d), wherein said epithelial cells are derived from mammalian corneal epithelial cells; (f) culturing said epithelial cells with said middle layer until said middle layer is covered with an external layer of epithelial cells; and, (g) continue culturing said inner, middle, and external layers under conditions to achieve a moist interface and forming a cornea equivalent.
Claim 8
Independent Claim
158 words
The method of producing a cornea equivalent comprising: (a) culturing endothelial cells to form an inner endothelial cell layer, wherein said endothelial cells are derived from mammalian corneal cells; (b) mixing stromal cells with collagen to achieve a stromal cell-collagen mixture, wherein said stromal cells are derived from mammalian corneal stromal fibroblast cells; (c) contacting said inner endothelial cell layer of step (a) with said stromal cell-collagen mixture of step (b), thereby forming a middle layer provided on said inner layer; (d) culturing said inner endothelial cell layer and said middle layer; (e) contacting epithelial cells onto said middle layer of step (d), wherein said epithelial cells are derived from mammalian corneal epithelial cells; (f) culturing said epithelial cells with said middle layer until said middle layer is covered with an external layer of epithelial cells; and, (g) continue culturing said inner, middle, and external layers under conditions to achieve a moist interface and forming a cornea equivalent.
Claim 9
Dependent Claim
27 words
The method of claim 6, wherein said endothelial cells of step (a) are derived from mammalian corneal endothelial cells transformed with the large T antigen of SV40.
Claim 10
Dependent Claim
38 words
The method as in either claim 6 or claim 7, wherein said endothelial cells are cultured in said first step by contacting said endothelial cells onto a porous membrane attached to the bottom of a cell culture insert.
Claim 11
Dependent Claim
20 words
The method of claim 8 wherein said porous membrane has a porosity of from about 0.2 micrometers to 10 micrometers.
Claim 12
Dependent Claim
20 words
The method of claim 8 wherein prior to said contacting, an acellular collagen layer is cast onto said porous membrane.
Claim 13
Dependent Claim
73 words
The method as in either claim 6 or claim 7, wherein the collagen in said stromal cell collagen mixture is selected from the group consisting of acid extracted bovine tendon collagen, enzyme extracted bovine tendon collagen, rat tail collagen, Type I collagen extracted from dermis, Type III collagen extracted from dermis, Type I collagen extracted from corneal stroma, Type V collagen extracted from corneal stroma, and Type VI collagen extracted from corneal stroma.
Claim 14
Dependent Claim
40 words
The method as in either claim 6 or claim 7, wherein said stromal cell-collagen mixture of said step (b) contains approximately 100 corneal stromal fibroblast cells per microgram collagen or 5×10 4 corneal stromal fibroblast cells/mL collagen and said collagen.
Claim 15
Dependent Claim
37 words
The method as in either claim 6 or claim 7, wherein said inner endothelial cell layer and said middle layer of said step (d) are cultured until said middle layer contracts to form a central raised area.
Claim 16
Dependent Claim
40 words
The method as in either claim 6 or 7, wherein said epithelial cells in said third step (e) are seeded on top of said middle layer of step (b) at a density of 7.2×10 4 -1.4×10 5 cells/cm 2 .
Claim 17
Dependent Claim
44 words
The method as in either claim 6 or 7, wherein said moist interface of said third step (g) is achieved by placing a droplet of tear film onto said external layer of epithelial cells or adding said tear film directly to the culture medium.
Claim 18
Dependent Claim
14 words
The method of claim 15, wherein said tear film comprises physiologic buffered salt solution.
Claim 19
Dependent Claim
30 words
The method of claim 16, wherein said physiologic buffered salt solution includes one or more components selected from the group consisting of protein-lipid surfactants, lipids, mucin, glycosaminoglycans, and hyaluronic acid.
Claim 20
Dependent Claim
29 words
The method as in either claim 6 or claim 7, wherein said moist surface interface of said third step (c) (iii) comprises a moisture loss prevention layer or membrane.
Claim 21
Dependent Claim
71 words
A cornea equivalent comprising: (a) an inner endothelial cell layer, wherein said endothelial cells are derived from the mammalian endothelial cells; (b) a middle stromal cell-collagen mixture layer, wherein said stromal cells are mammalian stromal fibroblasts derived from the group comprising sclera, dermis, tendon or fascia; and (c) an external epithelial cell layer, wherein said epithelial cells are mammalian epithelial keratinocytes derived from the group comprising corneal keratinocytes and scleral keratinocytes.
Claim 22
Dependent Claim
71 words
A cornea equivalent comprising: (a) an inner endothelial cell layer, wherein said endothelial cells are derived from the mammalian endothelial cells; (b) a middle stromal cell-collagen mixture layer, wherein said stromal cells are mammalian stromal fibroblasts derived from the group comprising sclera, dermis, tendon or fascia; and (c) an external epithelial cell layer, wherein said epithelial cells are mammalian epithelial keratinocytes derived from the group comprising corneal keratinocytes and scleral keratinocytes.
Claim 23
Independent Claim
162 words
The method of producing a cornea equivalent comprising: (a) culturing mammalian endothelial cells to form an inner endothelial cell layer; (b) mixing mammalian stromal cells with collagen to achieve a stromal cell-collagen mixture, wherein said stromal cells are mammalian stromal fibroblasts derived from sclera, dermis, tendon or fascia; (c) contacting said inner endothelial cell layer of step (a) with said stromal cell-collagen mixture of step (b), thereby forming a middle layer provided on said inner layer; (d) culturing said inner endothelial cell layer and said middle layer; (e) contacting mammalian epithelial cells onto said middle layer of step (d), wherein said epithelial cells are mammalian epithelial keratinocytes selected from the group consisting of corneal keratinocytes and scleral keratinocytes; (f) culturing said epithelial cells with said middle layer until said middle layer is covered with an external layer of epithelial cells; and, (g) continue culturing said inner, middle, and external layers under conditions to achieve a moist interface and forming a cornea equivalent.
Claim 24
Independent Claim
162 words
The method of producing a cornea equivalent comprising: (a) culturing mammalian endothelial cells to form an inner endothelial cell layer; (b) mixing mammalian stromal cells with collagen to achieve a stromal cell-collagen mixture, wherein said stromal cells are mammalian stromal fibroblasts derived from sclera, dermis, tendon or fascia; (c) contacting said inner endothelial cell layer of step (a) with said stromal cell-collagen mixture of step (b), thereby forming a middle layer provided on said inner layer; (d) culturing said inner endothelial cell layer and said middle layer; (e) contacting mammalian epithelial cells onto said middle layer of step (d), wherein said epithelial cells are mammalian epithelial keratinocytes selected from the group consisting of corneal keratinocytes and scleral keratinocytes; (f) culturing said epithelial cells with said middle layer until said middle layer is covered with an external layer of epithelial cells; and, (g) continue culturing said inner, middle, and external layers under conditions to achieve a moist interface and forming a cornea equivalent.
Claim 25
Dependent Claim
22 words
The cornea equivalent as in either claim 1 or claim 2 wherein said middle stromal cell-collagen mixture layer is uniform in thickness.
Claim 26
Dependent Claim
21 words
The cornea equivalent as in either claim 1 or claim 2 wherein said external epithelial cell layer is uniform in thickness.
Claim 27
Dependent Claim
25 words
The cornea equivalent as in either claim 1 or claim 2 wherein the suprabasal cells of said external epithelial cell layer exhibit reduced alpha-enolase activity.
Claim 28
Dependent Claim
24 words
The cornea equivalent as in either claim 1 or claim 2 wherein the suprabasal cells of said external epithelial cell layer expresses keratin 3.
Claim 29
Dependent Claim
33 words
The cornea equivalent as in either claim 1 or claim 2 wherein the junction between said middle stromal cell-collagen mixture layer and said external epithelial cell layer expresses laminin and type VII collagen.
Claim 30
Dependent Claim
31 words
The cornea equivalent as in either claim 1 or claim 2 wherein the junction between said middle stromal cell-collagen mixture layer and said external epithelial cell layer has a basement membrane.
Claim 31
Dependent Claim
24 words
The cornea equivalent as in either claim 1 or claim 2 wherein said external epithelial cell layer exhibits vermiform ridges on the epithelial surface.
Claim 32
Dependent Claim
26 words
The cornea equivalent as in either claim 1 or claim 2 wherein the suprabasal cells of said external epithelial cell layer exhibit tight junctions between cells.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-12-19 | 1998-06-20 | 1998-12-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-12-19 | 2002-06-20 | 2002-12-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-12-19 | 2006-06-20 | 2006-12-20 | $7700.00 | Window Closed / Lapsed |